Great Valley Advisor Group’s ARK Genomic Revolution ETF ARKG Stock Holding History

Great Valley Advisor Group’s Portfolio ARKG Stock Details ARKG Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell	-12,013	Closed	-$378K	–	675
2022 Q2	$378K	Buy	+12,013	New	+$420K	0.02%	492
2021 Q4	–	Sell	-7,800	Closed	-$583K	–	597
2021 Q3	$583K	Sell	7,800 -398	-5%	-$33.4K	0.04%	325
2021 Q2	$758K	Sell	8,198 -133	-2%	-$11.3K	0.06%	271
2021 Q1	$739K	Buy	8,331 +280	+3%	+$27.8K	0.07%	239
2020 Q4	$751K	Buy	8,051 +651	+9%	+$51.9K	0.08%	217
2020 Q3	$471K	Buy	7,400 +100	+1%	+$5.86K	0.06%	261
2020 Q2	$381K	Buy	7,300 +270	+4%	+$11.6K	0.06%	276
2020 Q1	$220K	Buy	+7,030	New	+$235K	0.06%	278

Other funds holding ARKG

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return

State of Wisconsin Investment Board Madison, Wisconsin $43.7B AUM 27.76% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Commonwealth Equity Services Waltham, Massachusetts $71.6B AUM 21.08% 1-Year Est. Return

Citigroup New York $235B AUM 32.99% 1-Year Est. Return

Great Valley Advisor Group's ARKG Position: Q3 2022 in Review

Great Valley Advisor Group sold out of ARK Genomic Revolution ETF (ARKG) in Q3 2022, closing a stake of 12,013 shares — an estimated $378K sold.

Great Valley Advisor Group first reported a position in ARKG in Q1 2020 and held it in 8 quarters. The position peaked at $758K in Q2 2021. 311 funds tracked by Wall St. Rank hold ARKG as of Q3 2022.

Great Valley Advisor Group reported no remaining ARK Genomic Revolution ETF position as of Q3 2022 after selling out during the quarter.
Great Valley Advisor Group sold 12,013 ARK Genomic Revolution ETF shares in Q3 2022, an estimated $378K.
Great Valley Advisor Group first reported a position in ARK Genomic Revolution ETF in Q1 2020 and held it in 8 quarters.
Great Valley Advisor Group's ARK Genomic Revolution ETF position peaked at $758K in Q2 2021.
311 funds tracked by Wall St. Rank held ARK Genomic Revolution ETF as of Q3 2022.

Based on Great Valley Advisor Group's 13F filing for Q3 2022, filed 21 Oct 2022.